Xcout Intel
Dravite Therapeutics, Inc.
Dravite Therapeutics, Inc. is a San Francisco, California-based private company operating in the therapeutics and drug development pipeline sector.
Subscribe to see Dravite Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dravite Therapeutics, Inc. at a glance
Dravite Therapeutics, Inc. is a company headquartered in United States. It has raised at least $68M across the 2 funding rounds on record. Its most recent funding round raised $53M in August 2026. Xcout tracks 8 named people at Dravite Therapeutics, Inc., including Joseph Sum (Executive Officer).
Dravite Therapeutics, Inc. leadership
- Joseph SumExecutive Officer
- Matthew MooreExecutive Officer
- Michael MooreExecutive Officer
- Barbara KosaczDirector
- Jeremy GoldbergDirector
- Joseph SumDirector
2 more named people on record for Dravite Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Dravite Therapeutics, Inc. funding rounds
At least $68M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $53M | — | |
| SEC Form D filing | $15M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Dravite Therapeutics, Inc. news
- FundingPrivate placement (Form D)
Dravite Therapeutics, Inc. competitors
A few of Dravite Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Deverra Therapeutics, Inc. is a private biotechnology company founded in 2015 and headquartered in Seattle, Washington, focused on developing drug pipelines and therapeutic solutions.
Iconic Therapeutics, Inc. is a subsidiary company based in South San Francisco, California, focusing on drug pipelines, patents, and clinical trials.
Perfuse Therapeutics, Inc. is a biopharmaceutical company pioneering treatments in clinical medicine, with operations based in San Francisco, California.
Soteria Biotherapeutics, Inc. is a biopharmaceutical company founded in 2018 and headquartered in San Francisco, California, specializing in biopharmaceutical advancements and drug pipelines.
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Blade Therapeutics, Inc. is a biopharmaceutical holding company headquartered in South San Francisco, California, focused on developing novel treatments for fibrotic diseases.
Get Dravite Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Dravite Therapeutics, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access